 contribution describes recent advances knowledge regulatory interactions two major oxidative fuels glucose lipid. also addresses metabolic abnormalities associated insulin resistance ischemic diseases impair ability skeletal muscle switch use alternative metabolic fuels ability adipose tissue function appropriately relation body's requirements triglyceride mobilisation storage, appropriate nutritional status. discuss targeting PPARs might ameliorate metabolic inflexibility muscle altered expression pyruvate dehydrogenase kinase (PDK) isoforms impact functions adipocyte lipid buffering energy homeostasis. Focus placed participation regulatory pyruvate dehydrogenase kinases, PPAR targets, beneficial potentially adverse actions PPARs metabolic control.